Changing to a dry powder inhaler (DPI) was associated with more healthcare use by adult patients with asthma, based on data from approximately 260,000 individuals. The Veterans Health Administration ...
What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...
The Food and Drug Administration (FDA) has approved Tyvaso DPI™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback